In our analysis, we found that higher CYP24A1 expression is associated with increased risk for MS (Wald ratio = 0.13, P = 7.8 × 10−11) and that the eQTL and GWAS signals are co-localized (PP4 = 1.00). Here, CYP24A1 is linked to myeloid sarcoma.